Viewing StudyNCT00006228



Ignite Creation Date: 2024-05-05 @ 10:00 AM
Last Modification Date: 2024-10-26 @ 9:05 AM
Study NCT ID: NCT00006228
Status: COMPLETED
Last Update Posted: 2013-10-08
First Post: 2000-09-11

Brief Title: Trastuzumab and Interleukin-2 in Treating Patients With Metastatic Breast Cancer
Sponsor: National Cancer Institute NCI
Organization: National Cancer Institute NCI

Conditions & Keywords Data

Conditions:
Name
HER2-positive Breast Cancer
Male Breast Cancer
Recurrent Breast Cancer
Stage IV Breast Cancer
Keywords: